EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels

Robert L Atmar iD, Khalil Ettayebi iD, Frederick H Neill, Ralph P Braun, James Sherwood, Sasirekha Ramani iD, Mary K Estes iD

The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · 1376-1379

DOI: 10.1093/infdis/jiae311 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 12.06.2024. Verfasst von Robert L Atmar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Blood Group Antigens, Caliciviridae Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Takeda Vaccines Business Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The in vitro cultivation of human noroviruses allows a comparison of antibody levels measured in neutralization and histo-blood group antigen (HBGA)–blocking assays.

Methods

Serum samples collected during the evaluation of an investigational norovirus vaccine (HIL-214 [formerly TAK-214]) were assayed for neutralizing antibody levels against the vaccine's prototype Norwalk virus/genogroup I, genotype 1 (GI.1) (P1) virus strain. Results were compared with those previously determined using HBGA-blocking assays.

Results

Neutralizing antibody seroresponses were observed in 83% of 24 vaccinated adults, and antibody levels were highly correlated (r = 0.81; P < .001) with those measured by HBGA blocking.

Conclusions

Genogroup I, genotype 1 (GI.1)–specific HBGA-blocking antibodies are a surrogate for neutralization of GI.1 norovirus. Clinical Trials Registration. Clinicaltrials.gov NCT02475278

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, ViralBlood Group AntigensCaliciviridae InfectionsGenotypeNorovirusAdultFemaleHumansMaleMiddle AgedYoung AdultAntibodies, BlockingNeutralization TestsNorwalk virusViral Vaccines

Stichwörter der Autor:innen

antibodyhisto-blood group antigenhuman norovirusneutralizationvaccine

Substanzen

Antibodies, BlockingAntibodies, NeutralizingAntibodies, ViralBlood Group AntigensViral Vaccines

Autor:innen und Institutionen

  • Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Icosavax, Seattle, Washington, USA.
  • Takeda Pharmaceuticals International, Zurich, Switzerland (former affiliation).

ORCID-Profile: Robert L Atmar, Khalil Ettayebi, Sasirekha Ramani, Mary K Estes

Förderung

  • Takeda Vaccines Business Unit

Zitieren

APA

Atmar, R. L., Ettayebi, K., Neill, F. H., Braun, R. P., Sherwood, J., Ramani, S., & Estes, M. K. (2024). Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels. The Journal of Infectious Diseases, 230(6), 1376-1379. https://doi.org/10.1093/infdis/jiae311

Vancouver

Atmar RL, Ettayebi K, Neill FH, Braun RP, Sherwood J, Ramani S, et al. Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels. The Journal of Infectious Diseases. 2024;230(6):1376-1379. doi:10.1093/infdis/jiae311

BibTeX
@article{Atmar2024,
  author = {Atmar, Robert L and Ettayebi, Khalil and Neill, Frederick H and Braun, Ralph P and Sherwood, James and Ramani, Sasirekha and Estes, Mary K},
  title = {Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {6},
  pages = {1376--1379},
  doi = {10.1093/infdis/jiae311}
}
Kostenlos starten →